UA78488C2 - Process for cleaning recombinant hcg and pharmaceutical composition - Google Patents

Process for cleaning recombinant hcg and pharmaceutical composition Download PDF

Info

Publication number
UA78488C2
UA78488C2 UA2002086890A UA2002086890A UA78488C2 UA 78488 C2 UA78488 C2 UA 78488C2 UA 2002086890 A UA2002086890 A UA 2002086890A UA 2002086890 A UA2002086890 A UA 2002086890A UA 78488 C2 UA78488 C2 UA 78488C2
Authority
UA
Ukraine
Prior art keywords
chromatography
solution
stage
column
purification
Prior art date
Application number
UA2002086890A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of UA78488C2 publication Critical patent/UA78488C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
UA2002086890A 2000-02-22 2001-01-22 Process for cleaning recombinant hcg and pharmaceutical composition UA78488C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00103690 2000-02-22
PCT/EP2001/000665 WO2001062773A1 (en) 2000-02-22 2001-01-22 PROCESS OF PURIFICATION OF hCG AND RECOMBINANT hCG PURIFIED BY THAT METHOD

Publications (1)

Publication Number Publication Date
UA78488C2 true UA78488C2 (en) 2007-04-10

Family

ID=8167925

Family Applications (2)

Application Number Title Priority Date Filing Date
UA2002086890A UA78488C2 (en) 2000-02-22 2001-01-22 Process for cleaning recombinant hcg and pharmaceutical composition
UAA200511832A UA86938C2 (uk) 2000-02-22 2001-01-22 РЕКОМБІНАНТНИЙ hCG ТА ЙОГО ЗАСТОСУВАННЯ ДЛЯ ВИГОТОВЛЕННЯ ЛІКАРСЬКОГО ЗАСОБУ ДЛЯ ЛІКУВАННЯ РОЗЛАДІВ, ПОВ'ЯЗАНИХ З БЕЗПЛІДНІСТЮ

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA200511832A UA86938C2 (uk) 2000-02-22 2001-01-22 РЕКОМБІНАНТНИЙ hCG ТА ЙОГО ЗАСТОСУВАННЯ ДЛЯ ВИГОТОВЛЕННЯ ЛІКАРСЬКОГО ЗАСОБУ ДЛЯ ЛІКУВАННЯ РОЗЛАДІВ, ПОВ'ЯЗАНИХ З БЕЗПЛІДНІСТЮ

Country Status (31)

Country Link
US (2) US7297777B2 (pl)
EP (2) EP1257564B1 (pl)
JP (1) JP4588960B2 (pl)
KR (1) KR100806911B1 (pl)
CN (1) CN100482679C (pl)
AT (1) ATE406378T1 (pl)
AU (2) AU783320B2 (pl)
BG (1) BG65807B1 (pl)
BR (1) BRPI0108556B8 (pl)
CA (1) CA2399020A1 (pl)
CY (1) CY1108460T1 (pl)
CZ (1) CZ303144B6 (pl)
DE (1) DE60135541D1 (pl)
DK (1) DK1257564T3 (pl)
EA (1) EA006605B1 (pl)
EE (1) EE05644B1 (pl)
ES (1) ES2307585T3 (pl)
HR (1) HRP20020650B1 (pl)
HU (2) HU228935B1 (pl)
IL (2) IL151308A0 (pl)
ME (1) ME00296B (pl)
MX (1) MXPA02007871A (pl)
NO (1) NO328694B1 (pl)
PL (1) PL205149B1 (pl)
PT (1) PT1257564E (pl)
RS (1) RS50741B (pl)
SI (1) SI1257564T1 (pl)
SK (1) SK287146B6 (pl)
UA (2) UA78488C2 (pl)
WO (1) WO2001062773A1 (pl)
ZA (1) ZA200206109B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE406378T1 (de) * 2000-02-22 2008-09-15 Serono Lab Verfahren zur reinigung vom recombinantem hcg mit spezifischer bioaktivität
JP2007513192A (ja) * 2004-10-04 2007-05-24 ノベタイド，リミティド ペプチド用の対イオン交換法
CN1958603B (zh) * 2005-11-04 2010-05-05 上海天伟生物制药有限公司 一种人绒毛膜促性腺素的纯化方法
WO2008007993A1 (fr) * 2006-07-11 2008-01-17 Koval, Anton Alexandrovich Utilisation d'une hormone chorionique ou lutéinisante destinée à la prévention ou au traitement de l'hypogonadisme lié à l'âge
CN101397339B (zh) * 2008-09-24 2012-07-25 上海天伟生物制药有限公司 糖蛋白中去除/灭活病毒的方法
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
CN101792481B (zh) * 2010-03-12 2012-05-30 丽珠医药集团股份有限公司 一种绒毛膜促性腺激素的纯化方法
WO2012120535A2 (en) * 2011-02-03 2012-09-13 Sanzyme Limited A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
US9757469B2 (en) 2011-03-31 2017-09-12 Ferring B.V. Pharmaceutical preparation
WO2013102921A2 (en) * 2011-11-17 2013-07-11 Sanzyme Limited Hcg - newer treatment modality for type 2 diabetes mellitus (t2dm)
CN103288950A (zh) * 2012-12-28 2013-09-11 青岛九龙生物医药有限公司 改进柱分离工序洗涤液和洗脱液配比去除杂质的方法
CN104101656A (zh) * 2013-04-01 2014-10-15 上海天伟生物制药有限公司 一种促性腺激素的纯度测定方法
US20150065426A1 (en) * 2013-08-27 2015-03-05 Professional Compounding Centers Of America Testosterone Booster Transdermal Compositions
CN105968185A (zh) * 2016-07-20 2016-09-28 宁波人健药业集团股份有限公司 一种绒促性素纯化方法
CN111233999B (zh) * 2020-03-21 2024-02-23 上海浦东明炎生物技术有限公司 一种从人尿中提取人绒毛膜促性腺激素的方法
CN113398251B (zh) * 2021-07-30 2022-08-05 宁波人健药业集团股份有限公司 一种重组人绒毛膜促性腺激素冻干粉针剂及其制备方法
CN116063452A (zh) * 2023-01-03 2023-05-05 杭州浦泰生物科技有限公司 一种人绒毛膜促性腺激素高效纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053864C (en) * 1989-02-21 2001-11-20 Irving Boime Modified forms of reproductive hormones
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.
IT1254370B (it) * 1992-05-22 1995-09-14 Sorin Biomedica Spa Procedimento per la purificazione di proteine da sistemi cellulari.
JP4165718B2 (ja) 1995-03-21 2008-10-15 ラボラトワール セローノ ソシエテ アノニム ｈＣＧ液体製剤
CN1082368C (zh) * 1995-03-21 2002-04-10 应用研究系统Ars股份公司 人绒毛膜促性腺激素液体制剂
JP4140927B2 (ja) * 1996-02-20 2008-08-27 アプライド リサーチ システムズ アース ホールディング エヌ．ヴィ． ヘテロ二量体を形成するハイブリッドタンパク質
IT1287138B1 (it) * 1996-11-07 1998-08-04 Ibsa Inst Biochimique Sa Procedimento per la separazione e purificazione di fsh e lh
WO1998056806A1 (en) 1997-06-12 1998-12-17 The Regents Of The University Of California A TRANSCRIPTION FACTOR COACTIVATOR PROTEIN, p/CIP
ES2287976T3 (es) * 1997-06-13 2007-12-16 Genentech, Inc. Recuperacion de proteinas mediante cromatografia seguida de filtracion sobre una capa cargada.
US6583109B1 (en) * 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
ATE406378T1 (de) * 2000-02-22 2008-09-15 Serono Lab Verfahren zur reinigung vom recombinantem hcg mit spezifischer bioaktivität

Also Published As

Publication number Publication date
CY1108460T1 (el) 2014-04-09
DE60135541D1 (de) 2008-10-09
IL151308A (en) 2009-11-18
DK1257564T3 (da) 2008-10-06
AU2680401A (en) 2001-09-03
EP1752466A2 (en) 2007-02-14
AU2006200059A1 (en) 2006-02-02
MXPA02007871A (es) 2003-02-10
IL151308A0 (en) 2003-04-10
CZ20022855A3 (cs) 2002-11-13
EE05644B1 (et) 2013-04-15
PL357508A1 (pl) 2004-07-26
MEP38908A (en) 2011-02-10
US20070299001A1 (en) 2007-12-27
EA006605B1 (ru) 2006-02-24
HRP20020650B1 (en) 2011-02-28
ES2307585T3 (es) 2008-12-01
CZ303144B6 (cs) 2012-05-02
BRPI0108556B8 (pt) 2021-05-25
NO328694B1 (no) 2010-04-26
SK12062002A3 (sk) 2002-12-03
US20030104553A1 (en) 2003-06-05
PT1257564E (pt) 2008-09-10
HK1052016A1 (zh) 2003-08-29
JP4588960B2 (ja) 2010-12-01
SI1257564T1 (sl) 2008-12-31
YU60202A (sh) 2005-09-19
NO20023985D0 (no) 2002-08-21
EP1752466A3 (en) 2012-10-10
HU1300063D0 (hu) 2003-03-28
UA86938C2 (uk) 2009-06-10
HRP20020650A2 (en) 2004-12-31
HU228935B1 (en) 2013-06-28
ME00296B (me) 2011-05-10
WO2001062773A1 (en) 2001-08-30
ZA200206109B (en) 2003-07-31
HUP0204231A3 (en) 2005-09-28
EP1257564A1 (en) 2002-11-20
CN100482679C (zh) 2009-04-29
EP1257564B1 (en) 2008-08-27
CN1404485A (zh) 2003-03-19
NO20023985L (no) 2002-08-21
BR0108556A (pt) 2003-01-28
US7297777B2 (en) 2007-11-20
EE200200469A (et) 2004-04-15
KR20030001359A (ko) 2003-01-06
PL205149B1 (pl) 2010-03-31
ATE406378T1 (de) 2008-09-15
CA2399020A1 (en) 2001-08-30
EA200200892A1 (ru) 2003-02-27
BG65807B1 (bg) 2009-12-31
BG107000A (en) 2003-04-30
RS50741B (sr) 2010-08-31
SK287146B6 (sk) 2010-01-07
BRPI0108556B1 (pt) 2015-04-14
HUP0204231A2 (hu) 2003-03-28
KR100806911B1 (ko) 2008-02-22
JP2003524015A (ja) 2003-08-12
AU783320B2 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
UA78488C2 (en) Process for cleaning recombinant hcg and pharmaceutical composition
AU606578B2 (en) Chromatographic recovery of erythropoietin
JP4959898B2 (ja) Ｌｈの精製
Eriksson et al. The manufacturing process for B-domain deleted recombinant factor VIII
Chaudhary et al. Purification of bubaline luteinizing hormone by gel filtration chromatography in the presence of blue dextran
HK1052016B (en) Process of purification of hcg
HK1052014B (en) Purified lh